Proceedings of the 2005 ACM/IEEE Symposium on Architecture for Networking and Communications Systems, ANCS 2005, Princeton, New Jersey, USA, October 16-18, 2005

A. Berenbaum,Kai Li,J. Turner

Abstract:

What problem does this paper attempt to address?

Current status on researches of Meniere’s disease: a review

Yupeng Liu,Jun Yang,Maoli Duan

DOI: https://doi.org/10.1080/00016489.2020.1776385

2020-06-21

Abstract:Background: Meniere's disease (MD) is a complex and multifactorial inner ear disease. The etiology of MD is unclear. Significant progress had been made in diagnosis and treatment. Complete cure for this disease is still impossible.Objectives: This review covers the updated research results in MD in the past decades.Material and methods: Recent publications were critically reviewed.Results: The relationship between Endolymphatic hydrops and Meniere symptoms requires further study. Direct visualization of EH is achieved by special sequences of inner ear MRI. Appearance of EH could be observed in MD patients both in symptomatic and asymptomatic ears. Visualization of EH in vivo might make a great substantial improvement in diagnose of MD. The first goal of the management of MD is to reduce the attack frequency. Several safe and effective medical and surgical therapies are practiced to help patients to control vertigo and preserve hearing.Conclusions and significance: There has been no major breakthrough in the pathogenesis research of MD in recent years. Visualization of EH in vivo might make a great substantial improvement in diagnose of MD. Clinicians still have few effective ways to alleviate the progress of the disease.

otorhinolaryngology
Current Understanding and Clinical Management of Meniere's Disease: A Systematic Review

Patricia Perez-Carpena,Jose A Lopez-Escamez,Jose A. Lopez-Escamez

DOI: https://doi.org/10.1055/s-0039-3402065

2019-12-30

Seminars in Neurology

Abstract:Abstract Meniere's disease (MD) is a set of uncommon disorders with core phenotype of tinnitus, episodic vertigo, and sensorineural hearing loss. MD shows a genetic predisposition and a family history is found in 10% cases, with an autosomal dominant inheritance pattern. It is a multifactorial condition whose onset and development are triggered by the combined effect of genetic and environmental factors. Histopathological studies have associated MD with the accumulation of endolymph in the cochlea and the vestibular organs. However, endolymphatic hydrops does not fully explain the persistence of tinnitus, hearing loss progression, or the frequency of vertigo attacks. There are several comorbidities associated with MD, such as migraine, anxiety, autoimmune, and autoinflammatory disorders, adding more complexity to the phenotype. This “extended phenotype” can make the diagnosis and clinical management more complex, but it could also lead to a better characterization, understanding, and treatment of MD patients. We have conducted a systematic review on MD to update current knowledge, focusing on its mechanisms, diagnosis, comorbidities, and practical management.

clinical neurology
The advance of genetics in Meniere's disease

Jiali Wang,Wuqing WANG

DOI: https://doi.org/10.3969/j.issn.1672-2922.2016.04.004

2016-01-01

Abstract:Ménière’s disease (MD) is a disorder of the inner ear with complex symptoms including fluctuating senso-rineural hearing loss, vertigo, tinnitus and aural fullness. MD etiology and pathophysiology are poorly understood. In this re-view we will discuss and summarize the genetic fundamentals of this disease.
The genomic landscape of Ménière's disease: a path to endolymphatic hydrops

Kathleen M Fisch,Sara Brin Rosenthal,Adam Mark,Roman Sasik,Chanond A Nasamran,Royce Clifford,M Jennifer Derebery,Ely Boussaty,Kristen Jepsen,Jeffrey Harris,Rick A Friedman

DOI: https://doi.org/10.1186/s12864-024-10552-3

IF: 4.547

2024-06-28

BMC Genomics

Abstract:Background: Ménière's disease (MD) is a disorder of the inner ear that causes episodic bouts of severe dizziness, roaring tinnitus, and fluctuating hearing loss. To date, no targeted therapy exists. As such, we have undertaken a large whole genome sequencing study on carefully phenotyped unilateral MD patients with the goal of gene/pathway discovery and a move towards targeted intervention. This study was a retrospective review of patients with a history of Ménière's disease. Genomic DNA, acquired from saliva samples, was purified and subjected to whole genome sequencing. Results: Stringent variant calling, performed on 511 samples passing quality checks, followed by gene-based filtering by recurrence and proximity in molecular interaction networks, led to 481 high priority MD genes. These high priority genes, including MPHOSPH8, MYO18A, TRIOBP, OTOGL, TNC, and MYO6, were previously implicated in hearing loss, balance, and cochlear function, and were significantly enriched in common variant studies of hearing loss. Validation in an independent MD cohort confirmed 82 recurrent genes. Pathway analysis pointed to cell-cell adhesion, extracellular matrix, and cellular energy maintenance as key mediators of MD. Furthermore, the MD-prioritized genes were highly expressed in human inner ear hair cells and dark/vestibular cells, and were differentially expressed in a mouse model of hearing loss. Conclusion: By enabling the development of model systems that may lead to targeted therapies and MD screening panels, the genes and variants identified in this study will inform diagnosis and treatment of MD.
Clinical Evaluation and Mitochondrial DNA Sequence Analysis in Two Chinese Families with Aminoglycoside-Induced and Non-Syndromic Hearing Loss.

LD Zhao,QJ Wang,YP Qian,RH Li,JY Cao,LC Hart,SQ Zhai,DY Han,WY Young,MX Guan

DOI: https://doi.org/10.1016/j.bbrc.2005.08.199

IF: 3.1

2005-01-01

Biochemical and Biophysical Research Communications

Abstract:We report here the clinical, genetic, and molecular characterization of two Chinese pedigrees with aminoglycoside-induced and non-syndromic hearing impairment. Clinical evaluation revealed the variable phenotype of hearing impairment including audiometric configuration in these subjects. Penetrances of hearing loss in BJ105 and BJ106 pedigrees are 67% and 33%, respectively. In particular, three of 10 affected matrilineal relatives of BJ105 pedigree had aminoglycoside-induced hearing loss, while seven affected matrilineal relatives in BJ105 pedigree and six affected matrilineal relatives in BJ106 pedigree did not have a history of exposure to aminoglycosides. Sequence analysis of the complete mitochondrial genomes in these pedigrees showed the identical homoplasmic A1555G mutation and distinct sets of mtDNA variants belonging to haplogroups F3 and M7b. These variants showed no evolutionary conservation, implying that mitochondrial haplotype may not play a significant role in the phenotypic expression of the A1555G mutation in these Chinese pedigrees. However, aminoglycosides and nuclear backgrounds appear to be major modifier factors for the phenotypic manifestation of the A1555G mutation in these Chinese families.
Mitochondria: 3-bromopyruvate vs. mitochondria? A small molecule that attacks tumors by targeting their bioenergetic diversity.

A. Galina

DOI: https://doi.org/10.1016/j.biocel.2014.05.013

2014-09-01

Abstract:
Current Understanding of Host Genetics of Otitis Media

Ruishuang Geng,Qingzhu Wang,Eileen Chen,Qing Yin Zheng

DOI: https://doi.org/10.3389/fgene.2019.01395

IF: 3.7

2020-02-07

Frontiers in Genetics

Abstract:The pathogenesis of otitis media (OM), an inflammatory disease of the middle ear (ME), involves interplay between many different factors, including the pathogenicity of infectious pathogens, host immunological status, environmental factors, and genetic predisposition, which is known to be a key determinant of OM susceptibility. Animal models and human genetics studies have identified many genes and gene variants associated with OM susceptibility: genes that encode components of multiple signaling pathways involved in host immunity and inflammatory responses of the ME mucosa; genes involved in cellular function, such as mucociliary transport, mucin production, and mucous cell metaplasia; and genes that are essential for Eustachian tube (ET) development, ME cavitation, and homeostasis. Since our last review, several new mouse models with mutations in genes such as CCL3, IL-17A, and Nisch have been reported. Moreover, genetic variants and polymorphisms in several genes, including FNDC1, FUT2, A2ML1, TGIF1, CD44, and IL1-RA variable number tandem repeat (VNTR) allele 2, have been identified as being significantly associated with OM. In this review, we focus on the current understanding of the role of host genetics in OM, including recent discoveries and future research prospects. Further studies on the genes identified thus far and the discovery of new genes using advanced technologies such as gene editing, next generation sequencing, and genome-wide association studies, will advance our understanding of the molecular mechanism underlying the pathogenesis of OM and provide new avenues for early screening and developing effective preventative and therapeutic strategies to treat OM.

genetics & heredity
Ménière's disease and allergy: Epidemiology, pathogenesis, and therapy

Wandi Xu,Xiaofei Li,Yongdong Song,Ligang Kong,Na Zhang,Jiahui Liu,Guorong Li,Zhaomin Fan,Yafeng Lyu,Daogong Zhang,Haibo Wang,Na Li

DOI: https://doi.org/10.1007/s10238-023-01192-0

IF: 4.6

2023-09-25

Clinical and Experimental Medicine

Abstract:The etiology of Ménière's disease (MD) remains controversial. Allergies are potential extrinsic factors that, in conjunction with underlying intrinsic factors, may cause MD. The link between allergies and MD was first described in 1923. For nearly a century, studies have demonstrated a possible link between allergies and MD, even though a causal relationship has not been definitively determined. Previous reviews have mainly focused on clinical epidemiology studies of patients. In this review, we shed light on the association between allergies and MD not only in terms of its epidemiology, but also from an immunology, pathophysiology, and immunotherapy perspective in both patients and animal models. Patients with MD tend to have a high risk of comorbid allergies or an allergy history, showing positive allergy immunology characteristics. Other MD-related diseases, such as migraine, may also interact with allergies. Allergy mediators such as IgE may worsen the symptoms of MD. Deposits of IgE in the vestibular end organs indicate the ability of the inner ear to participate in immune reactions. Allergic challenges can induce vertigo in animals and humans. Anti-allergy therapy plays a positive role in patients with MD and animal models of endolymphatic hydrops.

medicine, research & experimental
Cytokine profiling and transcriptomics in mononuclear cells define immune variants in Meniere Disease

Marisa Flook,Elena Rojano,Alvaro Gallego-Martinez,Alba Escalera-Balsera,Patricia Perez-Carpena,M. del Carmen Moleon,Rocio Gonzalez-Aguado,Victoria Rivero de Jesus,Emilio Domínguez-Durán,Lidia Frejo,Juan A. G. Ranea,Jose Antonio Lopez-Escamez

DOI: https://doi.org/10.1038/s41435-024-00260-z

2024-02-24

Genes and Immunity

Abstract:Meniere Disease (MD) is a chronic inner ear disorder characterized by vertigo attacks, sensorineural hearing loss, tinnitus, and aural fullness. Extensive evidence supporting the inflammatory etiology of MD has been found, therefore, by using transcriptome analysis, we aim to describe the inflammatory variants of MD. We performed Bulk RNAseq on 45 patients with definite MD and 15 healthy controls. MD patients were classified according to their basal levels of IL-1β into 2 groups: high and low. Differentially expression analysis was performed using the ExpHunter Suite, and cell type proportion was evaluated using the estimation algorithms xCell, ABIS, and CIBERSORTx. MD patients showed 15 differentially expressed genes (DEG) compared to controls. The top DEGs include IGHG1 ( p = 1.64 10 −6 ) and IGLV3-21 ( p = 6.28 10 −3 ), supporting a role in the adaptative immune response. Cytokine profiling defines a subgroup of patients with high levels of IL-1β with up-regulation of IL6 ( p = 7.65 10 −8 ) and INHBA ( p = 3.39 10 −7 ) genes. Transcriptomic data from peripheral blood mononuclear cells support a proinflammatory subgroup of MD patients with high levels of IL6 and an increase in naïve B-cells, and memory CD8 + T cells.

genetics & heredity,immunology
Multiple genetic variants involved in both autoimmunity and autoinflammation detected in Chinese patients with sporadic Meniere's disease: a preliminary study

Jing Zou,Guoping Zhang,Hongbin Li,Zikai Zhao,Qing Zhang,Ilmari Pyykkö,Antti Mäkitie

DOI: https://doi.org/10.3389/fneur.2023.1159658

IF: 3.4

2023-05-18

Frontiers in Neurology

Abstract:Background: The mechanisms of Meniere's disease (MD) remain largely unknown. The purpose of this study was to identify possible genetic variants associated with immune regulation in MD. Methods: The whole immune genome of 16 Chinese patients diagnosed with sporadic MD was sequenced using next-generation sequencing. Results: Definite pathological variants of MEFV (c.1223G>A, c.1105C>T), COL7A1 (c.5287C>T), and ADA (c.445C>T) contributing to the clinical phenotype were found in three patients. Limited and likely pathological variants of TLR3 (c.2228G>A) and RAB27A (c.560G>A) were detected in one patient each. The following definite pathological variants impairing the structure and function of translated proteins were detected in 10 patients, and multigene variants occurred in five patients: PRF1 ( c.710C > A ), UNC13D (c.1228A>C), COLEC11 (c.169C>T), RAG2 (c.200G>C), BLM (c.1937G>T), RNF31 (c.2533G>A), FAT4 (c.11498A>G), PEPD (c.788A>G), TNFSF12 (c.470G>A), VPS13B (c.11972A>T), TNFRSF13B (c.226G>A), ERCC6L2 (c.4613A>G), TLR3 (c.2228G>A), ADA (c.445C>T), PEPD (c.151G>A), and MOGS (c.2470G>A). The following limited pathological variants impairing the structure and function of translated proteins were detected in five patients, with double gene variants identified in one patient: EXTL3 (c.1396G>A), MTHFD1 (c.2057G>A), FANCA (c.2039T>C), LPIN2 (c.1814C>T), NBAS (c.4049T>C), and FCN3 (c.734G>A). Conclusion: Patients with sporadic MD carry multiple genetic variants involved in multiple steps of immune regulation, which might render patients susceptible to developing inflammation via both autoimmune and autoinflammation mechanisms upon internal stress.

neurosciences,clinical neurology
What is Menière’s disease? A contemporary re-evaluation of endolymphatic hydrops

R. Gürkov,I. Pyykö,J. Zou,E. Kentala

DOI: https://doi.org/10.1007/s00415-015-7930-1

2016-04-01

Journal of Neurology

Abstract:Menière’s disease is a chronic condition with a prevalence of 200–500 per 100,000 and characterized by episodic attacks of vertigo, fluctuating hearing loss, tinnitus, aural pressure and a progressive loss of audiovestibular functions. Over 150 years ago, Prosper Menière was the first to recognize the inner ear as the site of lesion for this clinical syndrome. Over 75 years ago, endolymphatic hydrops was discovered as the pathologic correlate of Menière’s disease. However, this pathologic finding could be ascertained only in post-mortem histologic studies. Due to this diagnostic dilemma and the variable manifestation of the various audiovestibular symptoms, diagnostic classification systems based on clinical findings have been repeatedly modified and have not been uniformly used in scientific publications on Menière’s disease. Furthermore, the higher level measures of impact on quality of life such as vitality and social participation have been neglected hitherto. Recent developments of high-resolution MR imaging of the inner ear have now enabled us to visualize in vivo endolymphatic hydrops in patients with suspected Menière’s disease. In this review, we summarize the existing knowledge from temporal bone histologic studies and from the emerging evidence on imaging-based evaluation of patients with suspected Menière’s disease. These indicate that endolymphatic hydrops is responsible not only for the full-blown clinical triad of simultaneous attacks of auditory and vestibular dysfunction, but also for other clinical presentations such as “vestibular” and “cochlear Menière’s disease”. As a consequence, we propose a new terminology which is based on symptomatic and imaging characteristics of these clinical entities to clarify and simplify their diagnostic classification.

clinical neurology
A Systematic Review on the Genetic Contribution to Tinnitus

Patricia Perez-Carpena,Jose A. Lopez-Escamez,Álvaro Gallego-Martinez

DOI: https://doi.org/10.1007/s10162-024-00925-6

2024-02-11

Journal of the Association for Research in Otolaryngology

Abstract:To assess the available evidence to support a genetic contribution and define the role of common and rare variants in tinnitus.

neurosciences,otorhinolaryngology
RotaRod and acoustic startle reflex performance of two potential mouse models for Meniere's disease

Vidya Babu,Rose Bahari,Nora Laban,Jacob Kulaga,Zahid Abdul,Basil Zakkar,Ahmad Al-Najjar,Joseph Lesus,Abd-Al-Rahman Al-Rifai,Heba Sattar,Suhitha Irukulla,Pranav Gunniya,Teresa Requena,Anna Lysakowski

DOI: https://doi.org/10.1111/ejn.16083

Abstract:Meniere's disease (MD) is a disorder of the inner ear characterized by chronic episodes of vertigo, tinnitus, increased aural pressure, and sensorineural hearing loss. Causes of MD are unknown, but endolymphatic hydrops is a hallmark. In addition, 5%-15% of MD cases have been identified as familial. Whole-genome sequencing studies of individuals with familial MD identified DTNA and FAM136A as candidate genes for autosomal dominant inheritance of MD. Although the exact roles of these genes in MD are unknown, FAM136A encodes a mitochondrial protein, and DTNA encodes a cytoskeletal protein involved in synapse formation and maintenance, important for maintaining the blood-brain barrier. It is also associated with a particular aquaporin. We tested vestibular and auditory function in dtna and fam136a knockout (KO) mice, using RotaRod and startle reflex-based clicker tests, respectively. Three-factor analysis of variance (ANOVA) results indicated that sex, age, and genotype were significantly correlated with reduced mean latencies to fall ("latencies") for male dtna KO mice, while only age was a significant factor for fam136a KO mice. Fam136a KO mice lost their hearing months before WTs (9-11 months vs. 15-20 months). In male dtna KO mice, divergence in mean latencies compared with other genotypes was first evident at 4 months of age, with older males having an even greater decrease. Our results indicate that fam136a gene mutations generate hearing problems, while dtna gene mutations produce balance deficits. Both mouse models should help to elucidate hearing loss and balance-related symptoms associated with MD.
Meniere's disease

Tsutomu Nakashima,Ilmari Pyykkö,Megan A. Arroll,Margaretha L. Casselbrant,Carol A. Foster,Nauman F. Manzoor,Cliff A. Megerian,Shinji Naganawa,Yi-Ho Young

DOI: https://doi.org/10.1038/nrdp.2016.28

IF: 81.5

2016-05-12

Nature Reviews Disease Primers

Abstract:Meniere's disease (MD) is a disorder of the inner ear that causes vertigo attacks, fluctuating hearing loss, tinnitus and aural fullness. The aetiology of MD is multifactorial. A characteristic sign of MD is endolymphatic hydrops (EH), a disorder in which excessive endolymph accumulates in the inner ear and causes damage to the ganglion cells. In most patients, the clinical symptoms of MD present after considerable accumulation of endolymph has occurred. However, some patients develop symptoms in the early stages of EH. The reason for the variability in the symptomatology is unknown and the relationship between EH and the clinical symptoms of MD requires further study. The diagnosis of MD is based on clinical symptoms but can be complemented with functional inner ear tests, including audiometry, vestibular-evoked myogenic potential testing, caloric testing, electrocochleography or head impulse tests. MRI has been optimized to directly visualize EH in the cochlea, vestibule and semicircular canals, and its use is shifting from the research setting to the clinic. The management of MD is mainly aimed at the relief of acute attacks of vertigo and the prevention of recurrent attacks. Therapeutic options are based on empirical evidence and include the management of risk factors and a conservative approach as the first line of treatment. When medical treatment is unable to suppress vertigo attacks, intratympanic gentamicin therapy or endolymphatic sac decompression surgery is usually considered. This Primer covers the pathophysiology, symptomatology, diagnosis, management, quality of life and prevention of MD.

medicine, general & internal
Inner ear pathologies impair sodium-regulated ion transport in Meniere’s disease

Andreas H. Eckhard,MengYu Zhu,Jennifer T. O’Malley,Gordon H. Williams,Johannes Loffing,Steven D. Rauch,Joe B. Nadol,M. Charles Liberman,Joe C. Adams

DOI: https://doi.org/10.1007/s00401-018-1927-7

IF: 15.887

2018-11-02

Acta Neuropathologica

Abstract:Meniere’s disease (MD), a syndromal inner ear disease, is commonly associated with a pathological accumulation of endolymphatic fluid in the inner ear, termed “idiopathic” endolymphatic hydrops (iEH). Although numerous precipitating/exacerbating factors have been proposed for MD, its etiology remains elusive. Here, using immunohistochemistry and in situ protein–protein interaction detection assays, we demonstrate mineralocorticoid-controlled sodium transport mechanisms in the epithelium of the extraosseous portion of the endolymphatic sac (eES) in the murine and human inner ears. Histological analysis of the eES in an extensive series of human temporal bones consistently revealed pathological changes in the eES in cases with iEH and a clinical history of MD, but no such changes were found in cases with “secondary” EH due to other otological diseases or in healthy controls. Notably, two etiologically different pathologies—degeneration and developmental hypoplasia—that selectively affect the eES in MD were distinguished. Clinical records from MD cases with degenerative and hypoplastic eES pathology revealed distinct intergroup differences in clinical disease presentation. Overall, we have identified for the first time two inner ear pathologies that are consistently present in MD and can be directly linked to the pathogenesis of EH, and which potentially affect the phenotypical presentation of MD.

pathology,neurosciences,clinical neurology
Genetics of Magnesium Disorders

Heng Li,Shiren Sun,Jianghua Chen,Goushuang Xu,Hanmin Wang,Qi Qian

DOI: https://doi.org/10.1159/000477730

2017-01-01

Kidney Diseases

Abstract:Background: Magnesium (Mg2+), the second most abundant cation in the cell, is woven into a multitude of cellular functions. Dysmagnesemia is associated with multiple diseases and, when severe, can be life-threatening. Summary: This review discusses Mg2+ homeostasis and function with specific focus on renal Mg2+ handling. Intrarenal channels and transporters related to Mg2+ absorption are discussed. Unraveling the rare genetic diseases with manifestations of dysmagnesemia has greatly increased our understanding of the complex and intricate regulatory network in the kidney, specifically, functions of tight junction proteins including claudin-14, -16, -19, and -10; apical ion channels including: TRPM6, K(v)1.1, and ROMK; small regulatory proteins including AC3 and ANK3; and basolateral proteins including EGF receptor, gamma-subunit (FXYD2) of Na-K-ATPase, K(ir)4.1, CaSR, CNNM2, and SLC41A. Although our understanding of Mg2+ handling of the kidney has expanded considerably in the last two decades, many questions remain. Future studies are needed to elucidate a multitude of unknown aspects of Mg2+ handling in the kidney. Key Message: Understanding rare and genetic diseases of Mg2+ dysregulation has expanded our knowledge and furthers the development of strategies for preventing and managing dysmagnesemia. (c) 2017 S. Karger AG, Basel
Identification of Potential Meniere's Disease Targets in the Adult Stria Vascularis

Shoujun Gu,Rafal Olszewski,Lacey Nelson,Alvaro Gallego-Martinez,Jose Antonio Lopez-Escamez,Michael Hoa

DOI: https://doi.org/10.3389/fneur.2021.630561

IF: 3.4

2021-02-05

Frontiers in Neurology

Abstract:The stria vascularis generates the endocochlear potential and is involved in processes that underlie ionic homeostasis in the cochlear endolymph, both which play essential roles in hearing. The histological hallmark of Meniere's disease (MD) is endolymphatic hydrops, which refers to the bulging or expansion of the scala media, which is the endolymph-containing compartment of the cochlea. This histologic hallmark suggests that processes that disrupt ion homeostasis or potentially endocochlear potential may underlie MD. While treatments exist for vestibular symptoms related to MD, effective therapies for hearing fluctuation and hearing loss seen in MD remain elusive. Understanding the potential cell types involved in MD may inform the creation of disease mouse models and provide insight into underlying mechanisms and potential therapeutic targets. For these reasons, we compare published datasets related to MD in humans with our previously published adult mouse stria vascularis single-cell and single-nucleus RNA-Seq datasets to implicate potentially involved stria vascularis (SV) cell types in MD. Finally, we provide support for these implicated cell types by demonstrating co-expression of select candidate genes for MD within SV cell types.

neurosciences,clinical neurology
Allergic diseases and Meniere's disease: a bidirectional Mendelian randomization

Hongru Qin,Meng Huang,Weiming Liang,Guojing Wu,Mengjia Tan,Junli Zhang,Wenyong Chen

DOI: https://doi.org/10.1016/j.bjorl.2024.101472

2024-07-20

Abstract:Objectives: Allergic diseases and Meniere's disease found to have a possible link in observational study. However, the potential causal relationship between the two is unclear. Therefore, we aimed to explore the causal relationship between allergic diseases and Meniere's disease using a new data analysis technique called bidirectional Mendelian randomization study. Method: Summary-level statistics for Meniere's disease and three allergic diseases (asthma, allergic rhinitis, eczema/dermatitis) were obtained from large-scale genome-wide association studies. The inverse variance weighted method was used as the primary measure, supplemented by MR-Egger regression and the weighted median method. To ensure the reliability of the conclusions, Cochran's Q, MR-Egger intercept, MR-PRESSO test, leave-one-out test, and MR Steiger test were used. Results: Inverse-variance weighted method showed asthma (p = 0.008, OR = 3.908, 95% CI 1.424-10.724, adjust_p = 0.024), allergic rhinitis (p = 0.026, OR = 24.714, 95% CI 1.479-412.827, adjust_p = 0.026) and eczema/dermatitis (p = 0.019, OR = 3725.954, 95% CI 3.795 to 3,658,399.580, adjust_p = 0.029) all had a significant effect on Meniere's disease. Reverse Mendelian randomization studies have shown that Meniere's disease does not increase the risk of three allergic diseases. Sensitivity analysis showed no horizontal pleiotropy and heterogeneity for each trait. Conclusion: Our Mendelian randomization analysis supports a positive causal relationship between three allergic diseases (asthma, allergic rhinitis, eczema/dermatitis) and Meniere's disease. This suggests that physicians should pay more attention to the Meniere's patient's allergy history and consider allergy avoidance as part of their treatment plan. Level of evidence: Mendelian Randomized (MR) studies are second only to randomized controlled trials in terms of the level of evidence.
Pharmacological Interventions for Menière's Disease: A Systematic Review and Network Meta-Analysis

Xian Zheng,Rui Lin

DOI: https://doi.org/10.1177/01455613241264421

2024-06-23

Ear Nose & Throat Journal

Abstract:Ear, Nose &Throat Journal, Ahead of Print. Objective: Evaluation of the effectiveness and posttreatment effects of intratympanic gentamicin and corticosteroids in treating patients with Ménière's disease (MD). Methods: Based on PubMed and Embase databases, randomized controlled trials using intratympanic injections of 4 drugs (gentamicin, methylprednisolone, dexamethasone, and placebo) for the treatment of MD were searched from 1995 to October 2023, and the literature was screened according to inclusion and exclusion criteria, and data were netted for meta-analysis using Stata 17. Results: A total of 13 studies were selected, involving 559 participants, with follow-up time ranging from 3 to 28 months. Meta-analysis showed that there was no statistically significant difference in pure-tone average between gentamicin and dexamethasone [standardized mean difference (SMD) = 0.09, 95% confidence interval (CI) (−0.42, 0.24), P < .05]. Compared to placebo, intratympanic injection of gentamicin [risk ratio (RR) = 1.18, 95% CI (0.43, 1.93)], methylprednisolone [RR = 0.88, 95% CI (0.07, 1.70)], and dexamethasone [RR = 0.70, 95% CI (−0.01, 1.41)] all showed better efficacy in treating vertigo. For the treatment of tinnitus, the SUCRA ranking results showed that dexamethasone was the most effective, followed by methylprednisolone and gentamicin. Conclusion: Pharmacological intervention is more effective than placebo in treating MD. Although gentamicin treatment shows significant effects in treating vertigo, corticosteroid combination therapy is markedly superior to gentamicin in controlling hearing loss and vertigo symptoms.

otorhinolaryngology
An Update on the Epidemiology and Clinicodemographic Features of Meniere's Disease

Emma De Ravin,Alexandra E. Quimby,Michael Bartellas,Sydnie Swanson,Tiffany P. Hwa,Douglas C. Bigelow,Jason A. Brant,Michael J. Ruckenstein

DOI: https://doi.org/10.1002/lary.31282

IF: 2.97

2024-01-19

The Laryngoscope

Abstract:Objective To characterize the estimated prevalence and clinicodemographic features of Ménière's disease (MD) using current diagnostic criteria. Methods A cross‐sectional study was undertaken at our tertiary academic referral center. All patients seen in Otolaryngology clinic with ICD‐10 diagnoses of MD, from January 1, 2013 to July 31, 2022 were identified. Chart review was undertaken to determine the estimated prevalence of MD meeting AAO‐HNS diagnostic criteria. Clinicodemographic features were evaluated against a comparator group without MD seen in our health system. Results Of 806 ICD‐10 diagnoses of MD, we identified 480 MD cases meeting diagnostic criteria (168 definite). Mean age at presentation for MD cases was 49 years. Forty‐seven percent of cases were male. A significantly higher proportion of MD cases than comparators were white (76% vs. 66%, p

medicine, research & experimental,otorhinolaryngology

Proceedings of the 2005 ACM/IEEE Symposium on Architecture for Networking and Communications Systems, ANCS 2005, Princeton, New Jersey, USA, October 16-18, 2005

Current status on researches of Meniere’s disease: a review

Current Understanding and Clinical Management of Meniere's Disease: A Systematic Review

The advance of genetics in Meniere's disease

The genomic landscape of Ménière's disease: a path to endolymphatic hydrops

Clinical Evaluation and Mitochondrial DNA Sequence Analysis in Two Chinese Families with Aminoglycoside-Induced and Non-Syndromic Hearing Loss.

Mitochondria: 3-bromopyruvate vs. mitochondria? A small molecule that attacks tumors by targeting their bioenergetic diversity.

Current Understanding of Host Genetics of Otitis Media

Ménière's disease and allergy: Epidemiology, pathogenesis, and therapy

Cytokine profiling and transcriptomics in mononuclear cells define immune variants in Meniere Disease

Multiple genetic variants involved in both autoimmunity and autoinflammation detected in Chinese patients with sporadic Meniere's disease: a preliminary study

What is Menière’s disease? A contemporary re-evaluation of endolymphatic hydrops

A Systematic Review on the Genetic Contribution to Tinnitus

RotaRod and acoustic startle reflex performance of two potential mouse models for Meniere's disease

Meniere's disease

Inner ear pathologies impair sodium-regulated ion transport in Meniere’s disease

Genetics of Magnesium Disorders

Identification of Potential Meniere's Disease Targets in the Adult Stria Vascularis

Allergic diseases and Meniere's disease: a bidirectional Mendelian randomization

Pharmacological Interventions for Menière's Disease: A Systematic Review and Network Meta-Analysis

An Update on the Epidemiology and Clinicodemographic Features of Meniere's Disease